Blue Owl Capital Holdings (CNTX) reports 3.19% beneficial stake in Context Therapeutics

Rhea-AI Filing Summary

Blue Owl Capital Holdings LP reported beneficial ownership of common stock of Context Therapeutics Inc. in Amendment No. 3 to its Schedule 13G. Blue Owl holds 2,934,015 shares of common stock, representing 3.19% of the class, based on 91,879,177 shares outstanding as of May 4, 2026.

Blue Owl has sole voting power and sole dispositive power over all 2,934,015 shares, with no shared voting or dispositive power. The ownership is now reported as 5 percent or less of the class, and Blue Owl disclaims that the report constitutes an admission of beneficial ownership for certain legal purposes.

Key Figures

Shares beneficially owned: 2,934,015 shares Ownership percentage: 3.19 % Shares outstanding: 91,879,177 shares +2 more

5 metrics

Shares beneficially owned 2,934,015 shares Common stock beneficially owned by Blue Owl Capital Holdings LP

Ownership percentage 3.19 % Percent of Context Therapeutics common stock class owned by Blue Owl

Shares outstanding 91,879,177 shares Common stock outstanding as of May 4, 2026, used to calculate ownership

Sole voting power 2,934,015.00 Shares over which Blue Owl has sole power to vote or direct the vote

Sole dispositive power 2,934,015.00 Shares over which Blue Owl has sole power to dispose or direct disposition

Key Terms

beneficially owned, Sole Voting Power, Sole Dispositive Power, Percent of class, +1 more

5 terms

beneficially owned financial

"Amount beneficially owned: See response to row 9 on the cover page"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"5 | Sole Voting Power 2,934,015.00 6 | Shared Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Sole Dispositive Power financial

"7 | Sole Dispositive Power 2,934,015.00 8 | Shared Dispositive Power 0.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Percent of class financial

"(b) | Percent of class: See response to row 11 on the cover page"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

Schedule 13G regulatory

"Pursuant to Rule 13d-4 of the Act, the Reporting Person declares"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 04:31 PM Accepted by SEC EDGAR 08/12/2026 - 04:30 PM Learn about SEC filing dates

FAQ

What percentage of Context Therapeutics (CNTX) shares does Blue Owl Capital Holdings own?

Blue Owl Capital Holdings reports ownership of 3.19% of Context Therapeutics’ common stock, holding 2,934,015 shares based on 91,879,177 shares outstanding as of May 4, 2026.

How many Context Therapeutics (CNTX) shares does Blue Owl Capital Holdings control?

Blue Owl Capital Holdings controls 2,934,015 shares of Context Therapeutics common stock, with sole voting power and sole dispositive power over all of these shares and no shared control.

Is Blue Owl Capital Holdings still a 5% beneficial owner of Context Therapeutics (CNTX)?

No. Blue Owl Capital Holdings reports ownership of 5 percent or less of Context Therapeutics’ common stock, specifically 3.19% of the outstanding shares as of May 4, 2026.

On what share count is Blue Owl’s 3.19% stake in Context Therapeutics (CNTX) based?

The reported 3.19% ownership is calculated using 91,879,177 shares of common stock outstanding as of May 4, 2026, as reported by Context Therapeutics.

Does Blue Owl Capital Holdings share voting or dispositive power over Context Therapeutics (CNTX) shares?

Blue Owl Capital Holdings reports sole voting power and sole dispositive power over 2,934,015 shares of Context Therapeutics, with no shared voting or dispositive power over any shares.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

Context Therapeutics Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

21077P108

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 21077P108

1

Names of Reporting Persons

Blue Owl Capital Holdings LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,934,015.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,934,015.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,934,015.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.19 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: The reported percentage is calculated based on 91,879,177 shares of Common Stock outstanding as of May 4, 2026, as reported on the Issuer's 10-Q filed with the Securities and Exchange Commission on May 6, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Context Therapeutics Inc.
(b)	Address of issuer's principal executive offices: 2001 Market Street, Suite 3915, Unit #15, Philadelphia, PA 19103
Item 2.
(a)	Name of person filing: This Statement is filed by Blue Owl Capital Holdings LP, referred to herein as the "Reporting Person."
(b)	Address or principal business office or, if none, residence: 399 Park Avenue, New York, New York 10022
(c)	Citizenship: See response to row 4 on the cover page hereto.
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 21077P108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to row 9 on the cover page hereto. Pursuant to Rule 13d-4 of the Act, the Reporting Person declares that filing this Statement shall not be deemed an admission that the Reporting Person is a beneficial owner of the reported securities, for purposes of Section 13(d) and/or Section 13(g) or for any other purpose.
(b)	Percent of class: See response to row 11 on the cover page hereto.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to row 5 on the cover page hereto.
	(ii) Shared power to vote or to direct the vote: See response to row 6 on the cover page hereto.
	(iii) Sole power to dispose or to direct the disposition of: See response to row 7 on the cover page hereto.
	(iv) Shared power to dispose or to direct the disposition of: See response to row 8 on the cover page hereto.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Blue Owl Capital Holdings LP

Signature:	/s/ Karen Hager
Name/Title:	Karen Hager / Chief Compliance Officer
Date:	08/11/2026